Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| AIM | PRESS-RELEASE | neutral | 3/10 | AIM ImmunoTech CEO issued a letter to shareholders addressing the recent FDA approval of daraxonrasib for pancreatic can | Sep 22, 2026 |
| ITRI | PRESS-RELEASE | neutral | 3/10 | Itron announced a strategic technology collaboration with Crytica Security to integrate Crytica's RDAi cybersecurity det | Sep 22, 2026 |
| ONMD | PRESS-RELEASE | neutral | 4/10 | OneMedNet Corporation announced a multi-year resale agreement with Atropos Health to expand commercial distribution of i | Sep 22, 2026 |
| PALI | PRESS-RELEASE | bullish | 6/10 | Palisade Bio announced FDA clearance of its IND application for PALI-2108, enabling initiation of the Phase 2 ASCENTRA-C | Sep 22, 2026 |
| PLRZ | PRESS-RELEASE | bullish | 6/10 | Polyrizon announced the enrollment of the first patient in its U.S. clinical study for NASARIX (PL-14), an investigation | Sep 22, 2026 |
| QNRX | PRESS-RELEASE | mixed | 5/10 | Quoin Pharmaceuticals announced FDA Fast Track Designation for QRX003 in Peeling Skin Syndrome, the first such designati | Sep 22, 2026 |
| MCHX | PRESS-RELEASE | neutral | 2/10 | Marchex has engaged PondelWilkinson, an investor relations firm, to support an expanded IR program aimed at increasing i | Sep 22, 2026 |
| TWG | PRESS-RELEASE | neutral | 4/10 | Top Wealth Group announced the relocation of its corporate headquarters from Hong Kong, China to Lille, France, signalin | Sep 22, 2026 |
| PDSB | PRESS-RELEASE | bullish | 7/10 | PDS Biotech published Phase 2 VERSATILE-002 results in JAMA Oncology showing 39.3-month median overall survival in ICI-n | Sep 22, 2026 |
| CNSY | PRESS-RELEASE | bullish | 5/10 | Cerenome subsidiary CNSide Diagnostics signed an in-network provider agreement with Blue Cross Blue Shield of Michigan, | Sep 22, 2026 |
| GBX | PRESS-RELEASE | bearish | 6/10 | Greenbrier announced 3,400 railcar orders valued at ~$600M in fiscal Q4 2026, including 780 units for Saudi Railway Comp | Sep 22, 2026 |
| CLVT | PRESS-RELEASE | neutral | 1/10 | Clarivate Plc announced it will report its Q3 2026 results on November 3, 2026. | Sep 22, 2026 |
| ZBIO | PRESS-RELEASE | neutral | 4/10 | Zenas BioPharma announced upcoming presentations of new data from the Phase 3 INDIGO open-label extension of obexelimab | Sep 22, 2026 |
| MLKN | PRESS-RELEASE | bullish | 6/10 | MillerKnoll reported Q2 fiscal 2026 EPS of $0.55, a 54.9% beat versus the $0.35 consensus estimate, with revenue of $943 | Sep 22, 2026 |
| ELDN | PRESS-RELEASE | bullish | 7/10 | Eledon Pharmaceuticals announced FDA Fast Track designation for tegoprubart in kidney transplantation and presented posi | Sep 22, 2026 |
| CGNX | PRESS-RELEASE | bullish | 6/10 | Cognex Corporation announced a definitive agreement to acquire RealSense, the market leader in depth-sensing cameras and | Sep 22, 2026 |
| MDWD | PRESS-RELEASE | bullish | 4/10 | MediWound received an additional $3.3 million from the U.S. Department of War to develop a room-temperature-stable formu | Sep 22, 2026 |
| UEC | PRESS-RELEASE | neutral | 1/10 | Uranium Energy Corp announced it will report its fiscal 2026 results on September 29, 2026. | Sep 22, 2026 |
| CLDX | PRESS-RELEASE | bullish | 7/10 | Celldex reported positive Phase 3 topline results for barzolvolimab in chronic spontaneous urticaria (CSU). Both EMBARQ- | Sep 22, 2026 |
| AZO | PRESS-RELEASE | bullish | 6/10 | AutoZone reported Q4 fiscal 2026 EPS of $56.05, beating the $53.89 consensus by 4.0%, on revenue of $6.59B (vs $6.70B co | Sep 22, 2026 |
| ACCV | PRESS-RELEASE | neutral | 5/10 | Accelevation launched the roadshow for its proposed IPO of 30 million shares (8.6M primary, 21.4M secondary) at an expec | Sep 22, 2026 |
| KIM | PRESS-RELEASE | neutral | 1/10 | Kimco Realty Corporation announced it will host a conference call on October 29, 2026 to discuss its Q3 results. | Sep 22, 2026 |
| VLN | PRESS-RELEASE | neutral | 4/10 | Valens Semiconductor announced a collaboration with onsemi to develop a cost-optimized integrated sensor based on the MI | Sep 22, 2026 |
| ALP | PRESS-RELEASE | neutral | 4/10 | Alpha Compute Corp. announced the execution of definitive agreements to acquire over 300 acres of Pennsylvania land with | Sep 22, 2026 |
| BEEM | PRESS-RELEASE | bullish | 6/10 | Beam Global announced a non-binding LOI to acquire a European drone technology company, aiming to become a vertically in | Sep 22, 2026 |
| HERE | PRESS-RELEASE | bearish | 6/10 | Here Group reported Q4 FY2026 revenue of RMB127.7M ($18.8M), up 94.1% YoY but down 22.5% sequentially, with a net loss o | Sep 22, 2026 |
| HGTY | PRESS-RELEASE | neutral | 2/10 | Broad Arrow Auctions, a subsidiary of Hagerty (HGTY), announced it will auction an ultra-rare 1990 MCA Centenaire (estim | Sep 22, 2026 |
| BZ | PRESS-RELEASE | neutral | 3/10 | Kanzhun Limited (BZ) declared an annual cash dividend of US$0.255 per ordinary share (US$0.510 per ADS), totaling approx | Sep 22, 2026 |
| TTEC | PRESS-RELEASE | neutral | 3/10 | TTEC announced the launch of a new customer experience operation in Cairo supporting Volkswagen Group UK, expanding its | Sep 22, 2026 |
| PHARM | PRESS-RELEASE | bullish | 6/10 | Pharming announced positive topline Phase II data for leniolisib in primary immunodeficiencies (PIDs) with immune dysreg | Sep 22, 2026 |